LEGISLATIVE FISCAL ESTIMATE

[First Reprint]

ASSEMBLY, No. 3242

STATE OF NEW JERSEY

222nd LEGISLATURE

 

DATED: FEBRUARY 27, 2026

 

 

SUMMARY

 

Synopsis:

Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

Type of Impact:

Annual expenditure increase to State and local government employers.

Agencies Affected:

Division of Pensions and Benefits in the Department of the Treasury; certain local government employers; Department of Banking and Insurance.

 

 

Office of Legislative Services Estimate

Fiscal Impact

 

Annual 

 

 

State Expenditure Increase for SHBP

 

$10,800

 

 

Local Expenditure Increase for SHBP/SEHBP

 

$18,000

 

 

Total Expenditure Increase for SHBP/SEHBP

 

$28,800

 

 

Local Expenditure Increase for Private Market Insurance

 

Indeterminate

 

 

 

 

·         The Office of Legislative Services (OLS) estimates that requiring the State Health Benefits Program and the School Employees’ Health Benefits Program to provide health insurance coverage for continuous glucose monitoring systems for the treatment of glycogen storage disease will annually increase State expenditures by approximately $10,800 and participating local government expenditures by approximately $18,000, for a combined total annual expenditure increase of $28,800. 

·         The OLS notes that local government employers, including school districts, which provide employee health insurance coverage through the private market, could also experience an indeterminate increase in annual costs.

BILL DESCRIPTION

 

      This bill requires health insurers, including the State Health Benefits Program and the School Employees’ Health Benefits Program, to provide coverage for a continuous glucose monitoring system for the treatment of glycogen storage disease.

 

 

FISCAL ANALYSIS

 

EXECUTIVE BRANCH

 

      The OLS has not received a formal fiscal note on this bill.  The New Jersey Mandated Health Benefits Advisory Commission submitted a report on a previous version of this bill, Assembly Bill No. 4628 of the 2024-2025 Session, to the General Assembly on May 16, 2025.  The commission indicated in its report that “[t]he average cost of [continuous glucose monitors] typically falls in a price range of $1,200-$3,600 per year.”

 

OFFICE OF LEGISLATIVE SERVICES

 

      The OLS estimates that requiring the State Health Benefits Program and the School Employees’ Health Benefits Program to provide health insurance coverage for continuous glucose monitoring systems for the treatment of glycogen storage disease will annually increase State expenditures by approximately $10,800 and participating local government expenditures by approximately $18,000, for a combined total annual expenditure increase of $28,800.  Local government employers, including school districts, which provide employee health insurance coverage through the private market, could also experience an indeterminate increase in annual costs.

      Research indicates that glycogen storage disease occurs in approximately 1 in 100,000 people.  This rate leads to an estimate of approximately eight people in total having glycogen storage disease that are covered under the State Health Benefits Program and the School Employees’ Health Benefits Program.  Under the bill, the State Health Benefits Program is estimated to provide coverage for approximately five people with glycogen storage disease, with three being covered by the State part and two being covered by the local part.  The School Employees’ Health Benefits Program is estimated to provide coverage for approximately three people with glycogen storage disease.

      Under the bill, the State is required to provide coverage for a continuous glucose monitoring system.  Each system has an upwards annual cost of $3,600, leading to increased State expenditures of approximately $10,800 and increased local government expenditures of approximately $18,000, for a combined total estimated expenditure increase of approximately $28,800.  The OLS does not know the exact extent to which the programs will cover the continuous glucose monitoring system, as this will depend on decisions made by the State Health Benefits Commission and the School Employees’ Health Benefits Commission.  This will ultimately impact costs for the State and participating local governments resulting from the provisions of the bill.

Section:

State Government

Analyst:

Camryn Mathews

Associate Fiscal Analyst

Approved:

Thomas Koenig

Legislative Budget and Finance Officer

 

This legislative fiscal estimate has been produced by the Office of Legislative Services due to the failure of the Executive Branch to respond to our request for a fiscal note.

 

This fiscal estimate has been prepared pursuant to P.L.1980, c.67 (C.52:13B-6 et seq.).